Health and Wellness

NAMS calls for cancer to be declared notifiable disease, backs indigenous HPV test and vaccine rollout

Published by
Saurav Gupta

The National Academy of Medical Sciences (NAMS) has called for cancer to be classified as a notifiable disease and expects the upcoming inclusion of indigenous HPV tests and vaccines in the national health programme to significantly enhance cancer prevention and treatment.

During its 65th foundation day on Monday, NAMS highlighted key findings from its task force on cervical and breast cancer, stressing the need for robust data collection to inform health surveillance and policy decisions.

Officials underscored that women over 30 should undergo regular cancer screening, pointing to low current coverage rates.

Dr Neerja Bhatla, professor and former head of Obstetrics and Gynaecology at All India Institute of Medical Sciences (AIIMS), vice president of NAMS, and founding head of the WHO Collaborating Centre for Cervical Cancer Prevention at AIIMS, spoke about the state of cervical cancer testing in India.

Also read: A Delhi doctor’s self-exam protocol for early breast cancer detection

Dr Bhatla noted that although HPV testing is the main diagnostic method, its cost has spurred the development of more affordable local alternatives. These tests, suitable for primary care centres and requiring minimal training, are expected to be integrated into national efforts.

She added that these cost-effective, validated HPV tests—which target fewer genotypes—are now available and compatible with portable equipment, allowing for same-day screening and treatment.

Regarding vaccinations, Health Minister JP Nadda had informed the Lok Sabha last August that the National Technical Advisory Group on Immunisation had recommended introducing the HPV vaccine into the national immunisation schedule.

However, issues around dosage (single vs double) and implementation logistics remain. While external experts back a single-dose regimen, the government must ensure readiness for rollout.

Indigenous single-dose HPV vaccine trials are currently underway, with interim findings expected by 2026 and final data by 2027.

Also read: Closure of mohalla clinics sparks fear and anger in Delhi

Dr Bhatla also claimed that if an individual is vaccinated at the age of 15, then cervical cancer cases can be prevented by 80%.

Saurav Gupta

With nearly six years of experience as a journalist, he has written extensively on developmental issues, policies, health, and government agency schemes across both print and digital platforms. He holds a BAJMC degree from IP University.

Published by
Saurav Gupta
Tags: cancer

Recent Posts

WFI should frame guidelines to balance interest of nation, athlete: Delhi HC on Phogat’s plea

Delhi HC asks WFI to create guidelines balancing national interest with women athletes’ careers after…

September 10, 2026

BRICS: Connaught Place to remain open, Delhi Metro Museum closed for three days

The clarification comes ahead of the summit, which will see India host leaders from 11…

September 10, 2026

Delhi Traffic Police asks DDCA to reschedule India-Afghanistan T20I due to BRICS Summit

Delhi Traffic Police seeks India-Afghanistan T20I postponement over BRICS Summit traffic and security arrangements in…

September 10, 2026

Delhi consumer commission orders bank to pay Rs 49,600 over failed Rs 10,000 ATM transaction

Bank ordered to refund Rs 10,000 and pay Rs 39,600 compensation and costs for failed…

September 10, 2026

‘Kala Hiran’ movie not in releasable form, makers tell Delhi HC in Salman Khan’s suit

Salman Khan’s ‘Kala Hiran’ suit: Delhi HC told the film is not ready for release…

September 10, 2026

KNMA opens two exhibitions exploring abstraction, ecology

KNMA’s two exhibitions bring together abstract art and ecological themes, examining geometry, plant life, memory,…

September 10, 2026